Matches in SemOpenAlex for { <https://semopenalex.org/work/W1917585596> ?p ?o ?g. }
- W1917585596 endingPage "1039" @default.
- W1917585596 startingPage "1032" @default.
- W1917585596 abstract "Abstract Background and Aim To evaluate the role of antiviral therapy with nucleoside analogs ( NA s) in sorafenib‐treated patients with hepatitis B virus ( HBV )‐related hepatocellular carcinoma ( HCC ). Methods A retrospective cohort study was done in 151 HBV ‐related HCC patients treated with sorafenib at S un Y at‐sen U niversity C ancer C enter between 2007 and 2012. Overall survival ( OS ), progression‐free survival and adverse events were compared in patients treated with/without NA s. Subgroup analysis and C ox regression analysis were performed to determine the efficiency of NA s and prognostic factors for OS . Results HBV ‐related HCC patients ( n = 151) were identified from our database of HCC patients treated with sorafenib. Patients treated with NA s (antiviral group, n = 88) had significantly improved OS compared with the patients who received no NA s (non‐antiviral group, n = 63; median OS : 16.47 months vs 13.10 months, P = 0.03). Patients in the antiviral group had a significant risk reduction of death compared with the non‐antiviral group (hazard ratio: 0.67, 95% confidence interval: 0.46–0.98, P = 0.04). By subgroup analysis, patients of B arcelona C linic L iver C ancer ( BCLC ) stage C and patients with higher presorafenib HBV ‐ DNA level achieved better survival improvement. Antiviral therapy with NA s was one of the independent prognostic factors for OS of HBV ‐related HCC patients who were treated with sorafenib. Conclusion Antiviral therapy with NA s improved OS of HBV ‐related HCC patients treated with sorafenib, especially in patients with BCLC stage C disease and higher HBV ‐ DNA level." @default.
- W1917585596 created "2016-06-24" @default.
- W1917585596 creator A5020613063 @default.
- W1917585596 creator A5025137178 @default.
- W1917585596 creator A5031263402 @default.
- W1917585596 creator A5048327095 @default.
- W1917585596 creator A5051070109 @default.
- W1917585596 creator A5055611906 @default.
- W1917585596 creator A5065079327 @default.
- W1917585596 creator A5086195415 @default.
- W1917585596 date "2015-04-27" @default.
- W1917585596 modified "2023-10-04" @default.
- W1917585596 title "Antiviral therapy in the improvement of survival of patients with hepatitis <scp>B</scp> virus‐related hepatocellular carcinoma treated with sorafenib" @default.
- W1917585596 cites W1859421852 @default.
- W1917585596 cites W1922647212 @default.
- W1917585596 cites W1971837077 @default.
- W1917585596 cites W1981815872 @default.
- W1917585596 cites W1989565979 @default.
- W1917585596 cites W1994193851 @default.
- W1917585596 cites W2000891625 @default.
- W1917585596 cites W2031000957 @default.
- W1917585596 cites W2033479689 @default.
- W1917585596 cites W2054887165 @default.
- W1917585596 cites W2064740570 @default.
- W1917585596 cites W2087671206 @default.
- W1917585596 cites W2104389844 @default.
- W1917585596 cites W2106787323 @default.
- W1917585596 cites W2110868099 @default.
- W1917585596 cites W2116836111 @default.
- W1917585596 cites W2132006978 @default.
- W1917585596 cites W2138477584 @default.
- W1917585596 cites W2139248078 @default.
- W1917585596 cites W2140387850 @default.
- W1917585596 cites W2140415000 @default.
- W1917585596 cites W2162741760 @default.
- W1917585596 cites W2163403599 @default.
- W1917585596 cites W2170670869 @default.
- W1917585596 cites W3030265267 @default.
- W1917585596 cites W4211105405 @default.
- W1917585596 cites W4245784696 @default.
- W1917585596 doi "https://doi.org/10.1111/jgh.12910" @default.
- W1917585596 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25639513" @default.
- W1917585596 hasPublicationYear "2015" @default.
- W1917585596 type Work @default.
- W1917585596 sameAs 1917585596 @default.
- W1917585596 citedByCount "19" @default.
- W1917585596 countsByYear W19175855962015 @default.
- W1917585596 countsByYear W19175855962016 @default.
- W1917585596 countsByYear W19175855962017 @default.
- W1917585596 countsByYear W19175855962018 @default.
- W1917585596 countsByYear W19175855962019 @default.
- W1917585596 countsByYear W19175855962020 @default.
- W1917585596 countsByYear W19175855962021 @default.
- W1917585596 countsByYear W19175855962022 @default.
- W1917585596 countsByYear W19175855962023 @default.
- W1917585596 crossrefType "journal-article" @default.
- W1917585596 hasAuthorship W1917585596A5020613063 @default.
- W1917585596 hasAuthorship W1917585596A5025137178 @default.
- W1917585596 hasAuthorship W1917585596A5031263402 @default.
- W1917585596 hasAuthorship W1917585596A5048327095 @default.
- W1917585596 hasAuthorship W1917585596A5051070109 @default.
- W1917585596 hasAuthorship W1917585596A5055611906 @default.
- W1917585596 hasAuthorship W1917585596A5065079327 @default.
- W1917585596 hasAuthorship W1917585596A5086195415 @default.
- W1917585596 hasConcept C126322002 @default.
- W1917585596 hasConcept C143998085 @default.
- W1917585596 hasConcept C159047783 @default.
- W1917585596 hasConcept C167135981 @default.
- W1917585596 hasConcept C185592680 @default.
- W1917585596 hasConcept C197934379 @default.
- W1917585596 hasConcept C207103383 @default.
- W1917585596 hasConcept C2522874641 @default.
- W1917585596 hasConcept C2776408679 @default.
- W1917585596 hasConcept C2776455275 @default.
- W1917585596 hasConcept C2776543447 @default.
- W1917585596 hasConcept C2776999253 @default.
- W1917585596 hasConcept C2777333352 @default.
- W1917585596 hasConcept C2777382497 @default.
- W1917585596 hasConcept C2777546739 @default.
- W1917585596 hasConcept C2778019345 @default.
- W1917585596 hasConcept C2778695046 @default.
- W1917585596 hasConcept C2780593183 @default.
- W1917585596 hasConcept C2993512173 @default.
- W1917585596 hasConcept C3020491458 @default.
- W1917585596 hasConcept C44249647 @default.
- W1917585596 hasConcept C71240020 @default.
- W1917585596 hasConcept C71924100 @default.
- W1917585596 hasConcept C90924648 @default.
- W1917585596 hasConceptScore W1917585596C126322002 @default.
- W1917585596 hasConceptScore W1917585596C143998085 @default.
- W1917585596 hasConceptScore W1917585596C159047783 @default.
- W1917585596 hasConceptScore W1917585596C167135981 @default.
- W1917585596 hasConceptScore W1917585596C185592680 @default.
- W1917585596 hasConceptScore W1917585596C197934379 @default.
- W1917585596 hasConceptScore W1917585596C207103383 @default.
- W1917585596 hasConceptScore W1917585596C2522874641 @default.
- W1917585596 hasConceptScore W1917585596C2776408679 @default.
- W1917585596 hasConceptScore W1917585596C2776455275 @default.